NEO — Neogenomics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Neogenomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	173	296	515	438	415
Net Total Accounts Receivable
Net Total Receivables	94.2	108	114	122	131
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	291	449	682	605	597
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	90.7	132	212	199	184
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	710	988	1,870	1,740	1,681
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	63.9	73.2	87.2	89.9	96.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	202	294	762	742	740
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	507	694	1,108	998	942
Total Liabilities & Shareholders' Equity	710	988	1,870	1,740	1,681
Total Common Shares Outstanding